N/A
N=55
Virtual Empowered Relief for Chronic Pain
Chronic Pain · Pain
Bottom Line
View on ClinicalTrials.gov: NCT05057988 ↗Enrolled (actual)
55
Serious AEs
0.0%
Results posted
Apr 2025
Primary outcome: Primary: Perceived Usefulness — 8.25 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Empowered Relief class (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Stanford University
- Primary completion
- Oct 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Perceived Usefulness |
8.25 | — |
| PRIMARY Participant Satisfaction |
8.59 | — |
| PRIMARY Likelihood of Using the Skills |
8.47 | — |
| SECONDARY Pain Bothersomeness |
5.9 | <.001 sig |
| SECONDARY PCS Total Scores |
19.02 | .208 |
| SECONDARY Pain Intensity |
5.58 | <.001 sig |
| SECONDARY PROMIS-Sleep Disturbance |
57.31 | .328 |
Summary
The purpose of the current pilot study is to examine a feasibility and the preliminary efficacy of Empowered Relief (ER) class when it is delivered 'virtually' to patients with chronic pain who take methadone or buprenorphine. The ER class is a single-session pain management class, which has demonstrated to be effective in improving pain and pain-related distress in patients with chronic low back pain, but its efficacy has not been examined in patients with chronic pain who take methadone or buprenorphine. Class participants will learn self-regulatory skills and develop a personalized plan to use the skills every day. The current study will examine a feasibility and participant's perception and satisfaction of this class at post-class. The study will also follow participants 3 months by administering 5 surveys (baseline, 2 weeks and 1 month, 2 months, and 3 months post-treatment) to determine whether the class confers the short-term and medium-term benefits across various aspects of health.
Eligibility Criteria
Inclusion Criteria
- Age at least 18 years old
- Chronic Pain (> 3 months)
- Taking Methadone or Buprenorphine
- English Fluency
Exclusion Criteria
- Pregnant,
- Gross Cognitive Impairment,
- Acute Suicidality,
- Severe Depression
Data sourced from ClinicalTrials.gov (NCT05057988). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.